HIV Drug Resistance Surveillance Guidance: 2015 Update

To minimize the emergence and spread of HIV drug resistance (HIVDR), the World Health Organization recommends HIV treatment scale-up be accompanied by measures to monitor and improve the quality of ART delivery and surveillance of HIVDR.

This update provides an overview of the essential elements that programme managers should include in programme planning to prevent and monitor the emergence of HIVDR. It also describes programmatic relevance and use of data.